Serum has applied for emergency approval of made-in-India covid vaccine: Poonawala
As promised, before the end of 2020, Serum Institute has applied for emergency use authorisation for the first made-in-India covid vaccine, Covishield, he tweeted
Adar Poonawalla has confirmed that Serum Institute of India has applied for emergency use authorisation for Covishield coronavirus vaccine. "As promised, before the end of 2020, @SerumInstIndia has applied for emergency use authorisation for the first made-in-India vaccine, COVISHIELD. This will save countless lives, and I thank the Government of India and Sri@narendramodiji for their invaluable support," the CEO of Serum Institute of India said in a tweet.
Serum Institute, the world's largest vaccine manufacturer, has entered into a collaboration with the University of Oxford and AstraZeneca to manufacture the vaccine.
This will be a landmark week for global fight against coronavirus. From Tuesday, the UK is all set to administer Pfizer Inc.’s covid vaccine while the US regulator is in all likelihood could approve the Pfizer vaccine for emergency use as early as Thursday.
According to the ICMR, the SII has already manufactured 40 million doses of the vaccine under the at-risk manufacturing and stockpiling license it obtained from the DCGI.
The Oxford covid vaccine is logistically feasible for distribution in India since it could be stored at two to eight degrees Celsius, say experts. (With Agency Inputs)
Unlock a world of Benefits! From insightful newsletters to real-time stock tracking, breaking news and a personalized newsfeed – it's all here, just a click away! Login Now!